Christopher S. Boerner Net Worth

Track Major Insider Updates On X/Twitter

Last Updated: 2 days, 6 hours ago

Christopher S. Boerner has an estimated net worth of at least $13.7 million*, as of Sept. 3, 2025. They own 250,878 shares of BMY stock. They have sold 29,532 shares of BMY stock since 2021, for an estimated $1.7 million.

Christopher S. Boerner $BMY SEC Form 4 Insider Trading

Christopher S. Boerner has filed a total of 4 insider trades in $BMY since 2021. Their most recent trade was a purchase of 2,000 shares, made on Feb 20, 2025. Their largest trade was a sale of 29,532 shares, made on Mar 14, 2022. We estimate that they now own 250,878 shares of $BMY, worth an estimated $12.0 million.

Insider Trading at $BMY

There have been a total of 45 insider trades reported at $BMY since 2021, with 23,474 shares purchased and 1.4 million shares sold. The most active insider traders in $BMY stock have been Giovanni Caforio, Rupert Vessey, and David V Elkins. The most recent trade was a sale of 56,000 shares reported by David V Elkins (EVP, Chief Financial Officer), made on Sep 02, 2025.

History of Insider Stock Trades by Christopher S. Boerner

Company Ticker	Purchase / Sale	Shares	Date	Disclosed (EST)
BMY	Purchase	2,000	Feb 20, 2025	Feb. 21, 2025, 8:09 p.m.
BMY	Purchase	2,000	Dec 05, 2023	Dec. 7, 2023, 7:06 p.m.
BMY	Purchase	3,071	Nov 28, 2023	Nov. 30, 2023, 7:32 p.m.
BMY	Sale	29,532	Mar 14, 2022	March 16, 2022, 7:32 p.m.

$BMY Executives and Stock Owners with Insider Trades

Giovanni Caforio, Board Chair and CEO
Rupert Vessey, EVP, Research & Early Dev.
David V Elkins, EVP, Chief Financial Officer
Autenried Paul Von, EVP, Chief Information Officer
Ann Powell, EVP, Chief Human Resources
Samit Hirawat, EVP,Chief Med.Offr.,Drug Dev.
Christopher S. Boerner, Chief Executive Officer
Sandra Leung, EVP, General Counsel
Christopher S. Boerner, EVP, Chief Commercial Officer
Benjamin Hickey, President, RayzeBio Org.
Giovanni Caforio, Chairman and CEO
Karen Murphy Santiago, SVP & Controller
Phil M Holzer, SVP and Controller
Rupert Vessey, EVP & President, Research
Bartie Wendy Short, EVP, Corporate Affairs
Robert M Plenge, EVP, Chief Research Officer
Adam Dubow, SVP,ChiefCompliance&EthicsOff.

*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.